Pharmaceutical Technology

MAY 25, 2023

The Medicines and Healthcare products Regulatory Agency (MHRA) aims to launch a pilot genetic biobank that will gather patient data to associate drug-related adverse events to their genetic makeup. The Yellow Card biobank will launch as a joint venture with the UK-government funded entity Genomics England on June 1.

Biobanking 130

Biobanking Genetics Genome Project Genome 130

Scienmag

JANUARY 17, 2022

A global effort to map the genomes of all plants, animals, fungi and other microbial life on Earth, is entering a new phase as it moves from pilot projects to full-scale production sequencing. This new phase of the The Earth BioGenome Project, or EBP, is marked with a collection of papers published this week (Jan. […].

Genome 84

Genome Genomics Production Genome Project 84

Scienmag

NOVEMBER 25, 2020

Researchers from the 10+ Wheat Genomes Project, led by Professor Curtis Pozniak (University […].

Genome 52

Genome Genomics Genome Project Genetics 52

Roots Analysis

AUGUST 28, 2022

The up-and-coming field of spatial genomics in biology promises to bridge the gap between high plex, high throughput, and high resolution. 70+ spatial Genomics solutions are developed by industry and non-industry players. 70+ spatial Genomics solutions are developed by industry and non-industry players. Concluding Remarks.

Genome 52

Genome Genomics RNA Genome Project 52

Pharmaceutical Technology

SEPTEMBER 15, 2022

From the Human Genome Project to contemporary drug development, collaboration is critical to the life sciences. They are where innovative companies can look to access research and tap into networks, cross-pollinating ideas and talent and testing products to accelerate development. Structured for business.

Life Science 130

Life Science Drug Delivery Genome Project Development 130

Roots Analysis

AUGUST 31, 2023

Nutrigenomics is the science studying the relationship between human genome, nutrition and health. In part, the success of the Human Genome Project has also paved a path for the novel concept of nutrigenomics. Similarly, people suffering from lactose intolerance must avoid milk products.

Genome 40

Genome Genomics Genetics Gene 40

The Pharma Data

APRIL 6, 2021

and European Union (EU) approvals, will also be presented, including long-term outcomes in patients with TRK fusion cancer receiving larotrectinib and data from the 100,000 Genomes Project analyzing the prognostic factor for survival for patients with tumors that harbor a neurotrophic receptor tyrosine kinase ( NTRK ) gene fusion.

Research 52

Research Genome Project Gene Genome 52